168 related articles for article (PubMed ID: 37167901)
21. Anticoagulation monitoring during pediatric extracorporeal membrane oxygenation.
Bembea MM; Schwartz JM; Shah N; Colantuoni E; Lehmann CU; Kickler T; Pronovost P; Strouse JJ
ASAIO J; 2013; 59(1):63-8. PubMed ID: 23263338
[TBL] [Abstract][Full Text] [Related]
22. aPTT-guided anticoagulation monitoring during ECMO support: A systematic review and meta-analysis.
Rajsic S; Treml B; Jadzic D; Breitkopf R; Oberleitner C; Bachler M; Bösch J; Bukumiric Z
J Crit Care; 2023 Oct; 77():154332. PubMed ID: 37244207
[TBL] [Abstract][Full Text] [Related]
23. Low-Dose Versus Therapeutic Anticoagulation in Patients on Extracorporeal Membrane Oxygenation: A Pilot Randomized Trial.
Aubron C; McQuilten Z; Bailey M; Board J; Buhr H; Cartwright B; Dennis M; Hodgson C; Forrest P; McIlroy D; Murphy D; Murray L; Pellegrino V; Pilcher D; Sheldrake J; Tran H; Vallance S; Cooper DJ;
Crit Care Med; 2019 Jul; 47(7):e563-e571. PubMed ID: 31033512
[TBL] [Abstract][Full Text] [Related]
24. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
[TBL] [Abstract][Full Text] [Related]
25. Activated Partial Thromboplastin Time Versus Anti-Factor Xa Monitoring of Heparin Anticoagulation in Adult Venoarterial Extracorporeal Membrane Oxygenation Patients.
Kulig CE; Schomer KJ; Black HB; Dager WE
ASAIO J; 2021 Apr; 67(4):411-415. PubMed ID: 33769995
[TBL] [Abstract][Full Text] [Related]
26. Conventional versus restricted anti-Xa-guided heparin protocol in adult patients undergoing extracorporeal membrane oxygenation.
Alkazemi A; Eche IM; Adra M; Cabezas F; Patel P; Rick K; Grandin EW
Artif Organs; 2022 Jan; 46(1):128-137. PubMed ID: 34725832
[TBL] [Abstract][Full Text] [Related]
27. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.
Buckley MS; Benanti GE; Meckel J; Tekle LA; Gilbert B; Puebla Neira D; McNierney DA; Korkames G; Yerondopoulos M; Park A; O'Hea JA; MacLaren R
Pharmacotherapy; 2023 Mar; 43(3):196-204. PubMed ID: 36759323
[TBL] [Abstract][Full Text] [Related]
28. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
29. Anti-Xa Assay Monitoring Improves the Precision of Anticoagulation in Venovenous Extracorporeal Membrane Oxygenation.
Hla TTW; Christou S; Sanderson B; Hanks F; Cameron L; Camporota L; Doyle AJ; Retter A
ASAIO J; 2024 Apr; 70(4):313-320. PubMed ID: 38039550
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulation Monitoring Under ECMO Support: A Comparative Study Between the Activated Coagulation Time and the Anti-Xa Activity Assay.
Delmas C; Jacquemin A; Vardon-Bounes F; Georges B; Guerrero F; Hernandez N; Marcheix B; Seguin T; Minville V; Conil JM; Silva S
J Intensive Care Med; 2020 Jul; 35(7):679-686. PubMed ID: 29768983
[TBL] [Abstract][Full Text] [Related]
31. Antifactor Xa Monitoring and Hematologic Complications of Pediatric Extracorporeal Membrane Oxygenation.
Rama G; Middlesworth W; Neunert C; Streltsova S; Cheung EW
ASAIO J; 2021 Jan; 67(1):91-95. PubMed ID: 33346994
[TBL] [Abstract][Full Text] [Related]
32. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
33. Discordance between ROTEM® clotting time and conventional tests during unfractionated heparin-based anticoagulation in intensive care patients on extracorporeal membrane oxygenation.
Prakash S; Wiersema UF; Bihari S; Roxby D
Anaesth Intensive Care; 2016 Jan; 44(1):85-92. PubMed ID: 26673593
[TBL] [Abstract][Full Text] [Related]
34. Coagulations Studies Do Not Correlate With Each Other or With Hematologic Complications During Pediatric Extracorporeal Membrane Oxygenation.
Deshpande SJ; Vitali S; Thiagarajan R; Brediger S; McManus M; Geva A
Pediatr Crit Care Med; 2021 Jun; 22(6):542-552. PubMed ID: 33660700
[TBL] [Abstract][Full Text] [Related]
35. Anti-Factor Xa-Based Anticoagulation during Extracorporeal Membrane Oxygenation: Potential Problems and Possible Solutions.
Ranucci M; Cotza M; Isgrò G; Carboni G; Ballotta A; Baryshnikova E;
Semin Thromb Hemost; 2020 Jun; 46(4):419-427. PubMed ID: 31563131
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a Multimodal Heparin Laboratory Monitoring Protocol in Adult Extracorporeal Membrane Oxygenation Patients.
Northam KA; Nguyen B; Chen SL; Sredzienski E; Charles A
J Pharm Pract; 2023 Feb; 36(1):79-86. PubMed ID: 34109859
[TBL] [Abstract][Full Text] [Related]
37. Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy.
Rhoades R; Leong R; Kopenitz J; Thoma B; McDermott L; Dovidio J; Barletti S; Gong JZ; Massey HT; McKenzie SE; Rame JE; Al-Rawas N
Thromb Res; 2021 Jul; 203():1-4. PubMed ID: 33894473
[No Abstract] [Full Text] [Related]
38. Anticoagulation Management during First Five Days of Infant-Pediatric Extracorporeal Life Support.
Bingham KR; Riley JB; Schears GJ
J Extra Corpor Technol; 2018 Mar; 50(1):30-37. PubMed ID: 29559752
[TBL] [Abstract][Full Text] [Related]
39. Systemic anticoagulation in ECMO.
Larabee SM; Hollinger LE; Vogel AM
Semin Pediatr Surg; 2023 Aug; 32(4):151333. PubMed ID: 37967498
[TBL] [Abstract][Full Text] [Related]
40. Association of Argatroban Dose With Coagulation Laboratory Test in Patients on Extracorporeal Membrane Oxygenation: Activated Clotting Time vs Activated Partial Thromboplastin Time.
Ahn HY; Jung Y; Kim TW; Cho YH; Yang JH; Chung CR; Min MS; Ko RE
Ann Pharmacother; 2024 Apr; 58(4):383-390. PubMed ID: 37401103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
